21Shares Files for Spot Injective (INJ) ETF, Propelling Altcoins into Institutional Spotlight

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.
Photo for article

NEW YORK, NY – October 21, 2025 – In a landmark development for the burgeoning altcoin market, 21Shares, a leading issuer of crypto exchange-traded products, officially filed an application with the U.S. Securities and Exchange Commission (SEC) yesterday, October 20, 2025, for a spot Injective (INJ) Exchange-T

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  246.03
-7.76 (-3.06%)
AAPL  307.34
-3.89 (-1.25%)
AMD  466.38
-56.82 (-10.86%)
BAC  53.83
-0.06 (-0.11%)
GOOG  365.76
-3.51 (-0.95%)
META  593.00
-34.57 (-5.51%)
MSFT  416.67
-11.38 (-2.66%)
NVDA  205.10
-13.56 (-6.20%)
ORCL  213.68
-22.66 (-9.59%)
TSLA  391.00
-27.45 (-6.56%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.